Baker Bros. Advisors’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,111
Closed -$553K 126
2021
Q2
$553K Hold
1,111
﹤0.01% 119
2021
Q1
$528K Sell
1,111
-16,019
-94% -$31.1M ﹤0.01% 125
2020
Q4
$30.2M Sell
17,130
-1,861
-10% -$2.46M 0.11% 46
2020
Q3
$18.2M Buy
18,991
+77
+0.4% +$82.7K 0.07% 56
2020
Q2
$22M Sell
18,914
-4,689
-20% -$4.24M 0.1% 47
2020
Q1
$21M Sell
23,603
-1,026
-4% -$1.11M 0.13% 41
2019
Q4
$21.6M Buy
+24,629
New +$19.2M 0.11% 45

Other funds holding KRRO

Baker Bros. Advisors's KRRO Position: Q3 2021 in Review

Baker Bros. Advisors sold out of Korro Bio (KRRO) in Q3 2021, closing a stake of 1,111 shares — an estimated $553K sold.

Baker Bros. Advisors first reported a position in KRRO in Q4 2019 and held it in 7 quarters. The position peaked at $30.2M in Q4 2020. 88 funds tracked by Wall St. Rank hold KRRO as of Q3 2021.

  • Baker Bros. Advisors reported no remaining Korro Bio position as of Q3 2021 after selling out during the quarter.
  • Baker Bros. Advisors sold 1,111 Korro Bio shares in Q3 2021, an estimated $553K.
  • Baker Bros. Advisors first reported a position in Korro Bio in Q4 2019 and held it in 7 quarters.
  • Baker Bros. Advisors's Korro Bio position peaked at $30.2M in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Korro Bio as of Q3 2021.

Based on Baker Bros. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.